Latest News - West Pharmaceutical
Top Corporates Hub
West Pharmaceutical
West to Host First-Quarter 2026 Conference Call
09.04.2026 10:00
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2026 financial results before the market opens on Thursday, April 23, 2026, and will follow with a conference call to discuss the results and business expectations at 8:00 a.m. Eastern Time.
Down 30% This Year: Analysts Say These 2 Beaten-Down Stocks Are Poised to Rebound
09.04.2026 09:59
‘Buy low and sell high’ is one of the most basic principles in investing, and it tends to stand out when fundamentally sound stocks trade at depressed levels. In many cases, those lower prices are exactly what create the opportunity. A declining share price doesn’t automatically mean the business is broken – the pressure may stem from issues that are temporary or fixable rather than structural. When the underlying fundamentals remain intact, analysts are often quick to flag the disconnect, givin
Does Dublin Automation Expansion Reshape the Bull Case for West Pharmaceutical Services’ Injectable Platform (WST)?
04.04.2026 01:14
In March 2026, West Pharmaceutical Services opened a 165,000-square-foot expansion at its Damastown, Dublin site, adding advanced automation and commercial-scale drug-handling capabilities to serve high-volume injectable therapies, including treatments for diabetes and obesity. This build-out deepens the West Vantage contract services platform, positioning West as a single-source partner from drug-device design through commercial manufacturing and regulatory support for injectable...
West Expands Dublin Facility to Support High-Volume Injectable Therapies, Including Diabetes and Obesity
31.03.2026 15:46
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today the opening of its new building at its current site in Damastown, Dublin. The 165,000 square foot expansion significantly enhances West's contract services and is designed to meet growing global demands of its customers' high-volume treatments, including diabetes and obesity.
Here's What to Expect From West Pharmaceutical's Next Earnings Report
31.03.2026 10:40
West Pharmaceutical is set to announce its first-quarter earnings soon, and Wall Street expects the company’s EPS to increase by double digits.
West Pharmaceutical CEO Plans Exit after 11 Years, Succession Process Underway
26.03.2026 05:02
West Pharmaceutical Services, Inc. (NYSE:WST) is included among the Dividend Kings and Aristocrats List: 32 Biggest Stocks. On March 9, Reuters reported that West Pharmaceutical Services, Inc. (NYSE:WST)’s chief executive, Eric Green, plans to retire once the company names his successor, ending an 11-year tenure in the role. The Pennsylvania-based company expects the transition to take […]
Will CEO Succession and Chair Role Debate Reshape West Pharmaceutical’s Governance Story (WST)?
16.03.2026 11:08
In early March 2026, West Pharmaceutical Services announced that long-time President, CEO and Board Chair Eric M. Green plans to retire in the second half of 2026, reaffirmed its February 12, 2026 guidance, and later received a shareholder proposal seeking to permanently separate the CEO and Chair roles, which the company urged investors to vote against at its May 4, 2026 annual meeting. This combination of a planned leadership transition, strong Q4 2025 results with reaffirmed guidance, and...
Stocks making the biggest moves midday: Rivian, Hims & Hers, BioNTech, Vertex Pharmaceuticals & more
10.03.2026 12:36
These are some of the stocks seeing the largest midday moves.
West Pharmaceutical Services, Inc. (WST) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
10.03.2026 11:00
West Pharmaceutical Services, Inc. (WST) Barclays 28th Annual Global Healthcare Conference March 10, 2026 9:00 AM EDTCompany ParticipantsEric Green -...
West to Participate in Upcoming Investor Conferences
27.02.2026 11:00
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following upcoming investor conferences:
Why West Pharmaceutical Services (WST) is a Top Momentum Stock for the Long-Term
25.02.2026 14:50
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
BofA Cuts West Pharmaceutical (WST) Target Following Model Update and Sector Pressure
24.02.2026 04:24
West Pharmaceutical Services, Inc. (NYSE:WST) is included among the 13 Best Strong Buy Dividend Stocks to Invest in. On February 13, BofA lowered its price recommendation on West Pharmaceutical Services, Inc. (NYSE:WST) to $300 from $370. It reiterated a Buy rating on the stock. The firm’s view followed what it described as “a solid finish […]
West Pharmaceutical Services (WST) is Returning to Sustainable Volume Growth
20.02.2026 14:30
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. In Q4 2025, Conestoga Capital Advisors Mid Cap Strategy returned -5.75% net of fees compared to the Russell Midcap Growth Index’s -3.70% return. The underperformance was driven by negative stock selection in the Technology […]
Are Wall Street Analysts Bullish on West Pharmaceutical Services Stock?
20.02.2026 13:00
West Pharmaceutical Services has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.
West Pharmaceutical Services (WST) Is Up 5.2% After Strong 2025 Results And 2026 Organic Growth Outlook
13.02.2026 00:22
In the past week, West Pharmaceutical Services reported its 2025 results, with full-year sales rising to US$3.07 billion and net income edging up to US$493.7 million, while also issuing 2026 guidance that calls for first-quarter net sales of US$770 million to US$790 million and full-year net sales of US$3.22 billion to US$3.28 billion, including a foreign-exchange benefit. An important detail in that outlook is that organic net sales growth is expected to outpace reported growth,...
WST's Q4 Earnings & Sales Beat, SmartDose Sale by Mid-2026, Stock Up
12.02.2026 18:07
West Pharmaceutical beats Q4 EPS and revenue estimates as proprietary products drive growth, while shares jump nearly 3.6% premarket on upbeat 2026 outlook.
West Pharmaceutical Services, Inc. Q4 2025 Earnings Call Summary
12.02.2026 17:32
Moby summary of West Pharmaceutical Services, Inc.'s Q4 2025 earnings call
West Pharmaceutical (WST) Reports Q4 Earnings: What Key Metrics Have to Say
12.02.2026 14:30
Although the revenue and EPS for West Pharmaceutical (WST) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
West Pharmaceutical Services, Inc. (WST) Q4 2025 Earnings Call Transcript
12.02.2026 14:14
West Pharmaceutical Services, Inc. (WST) Q4 2025 Earnings Call February 12, 2026 8:00 AM ESTCompany ParticipantsJohn Sweeney - Vice President of Investor...
West Pharmaceutical Services (NYSE:WST) Beats Q4 Earnings Estimates, Shares Surge
12.02.2026 12:33
West Pharmaceutical Services beats Q4 earnings estimates, driven by strong high-value product sales, leading to a significant stock price increase.